ANPI Angiotech Pharmaceuticals - Common Shares (MM)

Angiotech Pharmaceuticals to participate in JP Morgan Healthcare Conference VANCOUVER, Jan. 5 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), is scheduled to participate in the 23rd Annual JP Morgan Healthcare Conference. William Hunter, President and CEO will be making a 25-minute presentation at the conference on Wednesday, January 12th, 2005 at 1:30 pm PST (4:30 pm EST). A live webcast of Dr. Hunter's remarks will be available to all interested parties at Angiotech's website at http://www.angiotech.com/ in the Investor Relations section. To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes before the webcast begins. Vancouver-based Angiotech Pharmaceuticals, Inc., a specialty pharmaceutical company focusing on drug-eluting medical devices and biomaterials, is dedicated to enhancing the performance of medical devices and biomaterials through the innovative uses of pharmacotherapeutics. To find out more about Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), visit our website at http://www.angiotech.com/. CONTACTS: Todd Young, Angiotech Pharmaceuticals (Analysts & Investors) (604) 221-7676 ext 6933 Rui Avelar, Angiotech Pharmaceuticals, Inc. (Analysts) (604) 221-7676 ext 6996 Eric Starkman, Starkman & Associates (Media) (212) 252-8545 ext 12 DATASOURCE: Angiotech Pharmaceuticals, Inc. CONTACT: Todd Young, Angiotech Pharmaceuticals (Analysts & Investors), (604) 221-7676 ext. 6933; Rui Avelar, Angiotech Pharmaceuticals, Inc. (Analysts), (604) 221-7676 ext. 6996; Eric Starkman, Starkman & Associates (Media), (212) 252-8545 ext. 12

Copyright